Applications of CYP450 testing in the clinical setting

CF Samer, KI Lorenzini, V Rollason, Y Daali… - Molecular diagnosis & …, 2013 - Springer
Interindividual variability in drug response is a major clinical problem. Polymedication and
genetic polymorphisms modulating drug-metabolising enzyme activities (cytochromes P450 …

Stevens–Johnson syndrome and toxic epidermal necrolysis: an update

RP Dodiuk-Gad, WH Chung… - American journal of …, 2015 - Springer
Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening
mucocutaneous reactions, predominantly drug induced. The mortality rates for SJS and TEN …

Genetic variants associated with phenytoin-related severe cutaneous adverse reactions

WH Chung, WC Chang, YS Lee, YY Wu, CH Yang… - Jama, 2014 - jamanetwork.com
Importance The antiepileptic drug phenytoin can cause cutaneous adverse reactions,
ranging from maculopapular exanthema to severe cutaneous adverse reactions, which …

Pharmacogenetic variants and plasma concentrations of antiseizure drugs: a systematic review and meta-analysis

F Milosavljević, M Manojlović, L Matković… - JAMA network …, 2024 - jamanetwork.com
Importance Precise estimation of a patient's drug metabolism capacity is important for
antiseizure dose personalization. Objective To quantify the differences in plasma …

HLA‐associated antiepileptic drug‐induced cutaneous adverse reactions

KA Mullan, A Anderson, PT Illing, P Kwan, AW Purcell… - Hla, 2019 - Wiley Online Library
Adverse drug reactions (ADRs) are a common cause of hospital admissions (up to 19%),
with the majority of cases due to off‐target predictable drug effects (type A reactions) …

Precision medicine: does ethnicity information complement genotype-based prescribing decisions?

RR Shah, A Gaedigk - Therapeutic advances in drug safety, 2018 - journals.sagepub.com
Inter-ethnic differences in drug response are all too well known. These are underpinned by a
number of factors, including pharmacogenetic differences across various ethnic populations …

CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects

V Franco, E Perucca - Expert opinion on drug metabolism & …, 2015 - Taylor & Francis
Introduction: Phenytoin, a widely prescribed old-generation antiepileptic drug, requires
careful individualization of dosage to compensate for its prominent pharmacokinetic …

CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatment

CE Silvado, VC Terra… - Pharmacogenomics and …, 2018 - Taylor & Francis
Phenytoin (PHT) is an antiepileptic drug widely used in the treatment of focal epilepsy and
status epilepticus, and effective in controlling focal seizures with and without tonic–clonic …

[HTML][HTML] Efficacy and safety of levetiracetam versus (fos) phenytoin for second-line treatment of epilepticus: a meta-analysis of latest randomized controlled trials

Y Feng, Y Chen, Y Jia, Z Wang, X Wang, L Jiang, C Ai… - Seizure, 2021 - Elsevier
Objectives: To assess the efficiency and safety profiles of levetiracetam and (fos) phenytoin
(phenytoin or fosphenytoin) for second-line treatment of seizures by performing a meta …

[图书][B] A guide to the extrapyramidal side-effects of antipsychotic drugs

DGC Owens - 2014 - books.google.com
It is often implied that antipsychotic-induced extrapyramidal side-effects are irrelevant to
modern psychiatric therapeutics, rendered historic by newer, better treatments. This myth …